Dynamic Changes of Treg and Th17 Cells and Related Cytokines Closely Correlate With the Virological and Biochemical Response in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogues Treatment

Authors Information
Article Notes and Dates
To Cite : Yu X, Guo R, Su M, Ming D, Lin C, et al. Dynamic Changes of Treg and Th17 Cells and Related Cytokines Closely Correlate With the Virological and Biochemical Response in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogues Treatment, Hepat Mon. 2013 ;13(12):e15332. doi: 10.5812/hepatmon.15332.
Copyright: Copyright © 2013, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006; 28(1): 112-125
  • 2. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004; 38(10 Suppl 3)-68[PubMed]
  • 3. Chisari FV. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol. 2000; 156(4): 1117
  • 4. Juszczyk J, Boron-Kaczmarska A, Cianciara J, Flisiak R, Gladysz A, Halota W, et al. [Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations]. Pol Merkur Lekarski. 2010; 29(170): 103-6[PubMed]
  • 5. Dienstag JL. Hepatitis B virus infection. New Eng J Med. 2008; 359(14): 1486-1500
  • 6. Huang YW, Chayama K, Tsuge M, Takahashi S, Hatakeyama T, Abe H, et al. Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B. Antivir Ther. 2010; 15(2): 177-184
  • 7. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitro-expanded donor alloantigen-specific CD4+ CD25+ regulatory T cells promote experimental transplantation tolerance. Blood. 2007; 109(2): 827-835
  • 8. Xin L, Li Y, Soong L. Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo. Infect Immun. 2007; 75(10): 5018-26[DOI][PubMed]
  • 9. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology. 2008; 123(1): 57-65[DOI][PubMed]
  • 10. Franzese O, Kennedy PT, Gehring AJ, Gotto J, Williams R, Maini MK, et al. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol. 2005; 79(6): 3322-8[DOI][PubMed]
  • 11. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, et al. Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006; 177(1): 739-747
  • 12. Spolski R, Leonard WJ. Cytokine mediators of Th17 function. Eur J Immunol. 2009; 39(3): 658-61[DOI][PubMed]
  • 13. Zhang JY, Song CH, Shi F, Zhang Z, Fu JL, Wang FS. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One. 2010; 5(11)
  • 14. Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol. 2010; 30(1): 60-7[DOI][PubMed]
  • 15. Hohl TM, Rivera A, Pamer EG. Immunity to fungi. Curr Opin Immunol. 2006; 18(4): 465-72[DOI][PubMed]
  • 16. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev . 2008; 223(1): 87-113
  • 17. Su ZJ, Yu XP, Guo RY, Ming DS, Huang LY, Su ML, et al. Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B. Diagn Microbiol Infect Dis. 2013; 76(4): 437-44[DOI][PubMed]
  • 18. Xue-Song L, Cheng-Zhong L, Ying Z, Mo-Bin W. Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection. BMC Gastroenterol. 2012; 12: 43[DOI][PubMed]
  • 19. Zheng Y, Huang Z, Chen X, Tian Y, Tang J, Zhang Y, et al. Effects of telbivudine treatment on the circulating CD4(+) T-cell subpopulations in chronic hepatitis B patients. Mediators Inflamm. 2012; 2012: 789859[DOI][PubMed]
  • 20. Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, et al. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antiviral Res. 2011; 91(1): 23-31[DOI][PubMed]
  • 21. Chinese Medical Association Chinese Medical Association. [The guideline of prevention and treatment for chronic hepatitis B (2010 version)]. J clin hepatol. 2011; 27(1): 113-28
  • 22. Karino Y, Toyota J, Kumada H, Katano Y, Izumi N, Kobashi H, et al. Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B. Hepatol Int. 2010; 4(1): 414-22[DOI][PubMed]
  • 23. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Rev Immunol. 2005; 5(3): 215-229
  • 24. Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest. 1998; 102(5): 968
  • 25. Boni C, Penna A, Bertoletti A, Lamonaca V, Rapti I, Missale G, et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol. 2003; 39(4): 595-605
  • 26. Zhang PY, Yao SM, Fan Z, Zhang MX, Wei L, Jing Y, et al. Dynamic Changes of Multiple Immune Cells in Chronic Hepatitis B Patients Undergoing Antiviral Treatment. Infect Int. 2012; 1(1): 39-45
  • 27. Wang Q, Zheng Y, Huang Z, Tian Y, Zhou J, Mao Q, et al. Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol. 2011; 12: 25[DOI][PubMed]
  • 28. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006; 177(1): 739-47[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check